Systematic evaluation of different nucleic acid amplification assays for cytomegalovirus detection: Feasibility of blood donor screening

Journal of Clinical Microbiology

Volumn 53, Issue 10, 2015, Pages 3219-3225

  Vollmer, T ^a   Knabbe, C ^a   Dreier, J ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS DNA; DIAGNOSTIC KIT;

ADULT; ARTICLE; ASYMPTOMATIC INFECTION; BIOASSAY; BLOOD DONOR; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA DETERMINATION; DNA EXTRACTION; FEASIBILITY STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIMIT OF DETECTION; MALE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY ANALYSIS; SEROCONVERSION; VIRUS DETECTION; VIRUS TRANSMISSION; YOUNG ADULT; ADOLESCENT; ANIMAL; BLOOD; COMPARATIVE STUDY; CYTOMEGALOVIRUS INFECTIONS; DIAGNOSTIC KIT; EVALUATION STUDY; MASS SCREENING; MOLECULAR DIAGNOSIS; PLASMA; PROCEDURES; SENSITIVITY AND SPECIFICITY; VIROLOGY;

ADOLESCENT; ADULT; ANIMALS; BLOOD DONORS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; HUMANS; MALE; MASS SCREENING; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PLASMA; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84941985286     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01091-15     Document Type: Article

References (28)

1. de Medeiros CR, Moreira VA, Pasquini R. 2000. Cytomegalovirus as a cause of very late interstitial pneumonia after bone marrow transplantation. Bone Marrow Transplant 26:443-444. http://dx. doi. org/10. 1038/sj . bmt. 1702538.
2. Manez R, Kusne S, Martin M, Linden P, Irish W, Torre-Cisneros J, Kramer D, Ho M, Starzl TE. 1993. The impact of blood transfusion on the occurrence of pneumonitis in primary cytomegalovirus infection after liver transplantation. Transfusion 33:594-597. http://dx. doi. org/10. 1046 /j. 1537-2995. 1993. 33793325057. x.
3. Hecker M, Qiu D, Marquardt K, Bein G, Hackstein H. 2004. Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sang 86:41-44. http://dx. doi. org/10. 1111/j. 0042-9007. 2004 . 00388. x.
4. Vamvakas EC. 2005. Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis. Transfus Med Rev 19:181-199.
5. Ziemann M, Hennig H. 2014. Prevention of transfusion-transmitted cytomegalovirus infections: which is the optimal strategy? Transfus Med Hemother 41:40-44.
6. Ziemann M, Juhl D, Gorg S, Hennig H. 2013. The impact of donor cytomegalovirus DNA on transfusion strategies for at-risk patients. Transfusion 53:2183-2189.
7. Souza MA, Passos AM, Treitinger A, Spada C. 2010. Seroprevalence of cytomegalovirus antibodies in blood donors in southern Brazil. Rev Soc Bras Med Trop 43:359-361. http://dx. doi. org/10. 1590/S0037-86822010000400004.
8. Galea G, Urbaniak SJ. 1993. Cytomegalovirus studies on blood donors in north-east Scotland and a review of UK data. Vox Sang 64:24-30. http: //dx. doi. org/10. 1111/j. 1423-0410. 1993. tb02510. x.
9. Schennach H, Hessenberger G, Mayersbach P, Schonitzer D, Fuchs D. 2002. Acute cytomegalovirus infections in blood donors are indicated by increased serum neopterin concentrations. Med Microbiol Immunol 191: 115-118. http://dx. doi. org/10. 1007/s00430-002-0148-8.
10. Ziemann M, Unmack A, Steppat D, Juhl D, Gorg S, Hennig H. 2010. The natural course of primary cytomegalovirus infection in blood donors. Vox Sang 99:24-33. http://dx. doi. org/10. 1111/j. 1423-0410. 2009 . 01306. x.
11. Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF. 1999. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 180:702-707. http://dx. doi. org/10 . 1086/314939.
12. Preiksaitis JK. 2003. Prevention of transfusion-acquired CMV infection: is there a role for NAT? Transfusion 43:302-305. http://dx. doi. org/10 . 1046/j. 1537-2995. 2003. 00373. x.
13. Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD. 2000. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 355:2032-2036. http://dx. doi. org/10. 1016/S0140-6736(00)02350-3.
14. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, Allen U, Humar A. 2010. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 89:779-795. http://dx. doi. org/10. 1097 /TP. 0b013e3181cee42f.
15. Roback JD, Hillyer CD, Drew WL, Laycock ME, Luka J, Mocarski ES, Slobedman B, Smith JW, Soderberg-Naucler C, Todd DS, Woxenius S, Busch MP. 2001. Multicenter evaluation of PCR methods for detecting CMVDNAin blood donors. Transfusion 41:1249-1257. http://dx. doi. org /10. 1046/j. 1537-2995. 2001. 41101249. x.
16. Drew WL, Roback JD. 2007. Prevention of transfusion-transmitted cytomegalovirus: reactivation of the debate? Transfusion 47:1955-1958. http://dx. doi. org/10. 1111/j. 1537-2995. 2007. 01494. x.
17. Dumont LJ, Luka J, VandenBroeke T, Whitley P, Ambruso DR, Elfath MD. 2001. The effect of leukocyte-reduction method on the amount of human cytomegalovirus in blood products: a comparison of apheresis and filtration methods. Blood 97:3640-3647. http://dx. doi. org/10. 1182/blood . V97. 11. 3640.
18. Ziemann M, Krueger S, Maier AB, Unmack A, Goerg S, Hennig H. 2007. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion. Transfusion 47:1972-1983. http://dx. doi. org/10. 1111/j. 1537-2995. 2007. 01420. x.
19. Yeager AS, Grumet FC, Hafleigh EB, Arvin AM, Bradley JS, Prober CG. 1981. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr 98:281-287. http://dx. doi. org/10. 1016/S0022-3476(81)80662-2.
20. Roback JD, Drew WL, Laycock ME, Todd D, Hillyer CD, Busch MP. 2003. CMV DNA is rarely detected in healthy blood donors using validated PCR assays. Transfusion 43:314-321. http://dx. doi. org/10. 1046/j . 1537-2995. 2003. 00312. x.
21. Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L, McCullough J, Miller W. 1995. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusionassociated CMV infection after marrow transplant. Blood 86:3598-3603.
22. Lieberman L, Devine DV, Reesink HW, Panzer S, Wong J, Raison T, Benson S, Pink J, Leitner GC, Horvath M, Compernolle V, Prado Scuracchio PS, Wendel S, Delage G, Nahirniak S, Dongfu X, Krusius T, Juvonen E, Sainio S, Cazenave JP, Guntz P, Kientz D, Andreu G, Morel P, Seifried E, Hourfar K, Lin CK, O'Riordan J, Raspollini E, Villa S, Rebulla P, Flanagan P, Teo D, Lam S, Ang AL, Lozano M, Sauleda S, Cid J, Pereira A, Ekermo B, Niederhauser C, Waldvogel S, Fontana S, Desborough MJ, Pawson R, Li M, Kamel H, Busch M, Qu L, Triulzi D. 2014. Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: standards of care. Vox Sang 107:276-311. http://dx. doi. org/10 . 1111/vox. 12103.
23. Roback JD, Josephson CD. 2013. New insights for preventing transfusion-transmitted cytomegalovirus and other white blood cell-associated viral infections. Transfusion 53:2112-2116.
24. Drew WL, Tegtmeier G, Alter HJ, Laycock ME, Miner RC, Busch MP. 2003. Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients. Transfusion 43:309-313. http://dx. doi. org /10. 1046/j. 1537-2995. 2003. 00337. x.
25. Diosi P, Moldovan E, Tomescu N. 1969. Latent cytomegalovirus infection in blood donors. Br Med J 4:660-662. http://dx. doi. org/10. 1136/bmj . 4. 5684. 660.
26. Bayer WL, Tegtmeier GE. 1976. The blood donor: detection and magni-tude of cytomegalovirus carrier states and the prevalence of cytomegalovirus antibody. Yale J Biol Med 49:5-12.
27. Boeckh M, Gallez-Hawkins GM, Myerson D, Zaia JA, Bowden RA. 1997. Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. Transplantation 64:108-113. http://dx. doi. org/10 . 1097/00007890-199707150-00020.
28. Tang W, Elmore SH, Fan H, Thorne LB, Gulley ML. 2008. Cytomegalovirus DNA measurement in blood and plasma using Roche LightCycler CMV quantification reagents. Diagn Mol Pathol 17:166-173. http://dx. doi. org/10. 1097/PDM. 0b013e3181599242.